3D Spectrophotometry of Planetary Nebulae in the Bulge of M31

We introduce crowded field integral field (3D) spectrophotometry as a useful technique for the study of resolved stellar populations in nearby galaxies. As a methodological test, we present a pilot study with selected extragalactic planetary nebulae (XPN) in the bulge of M31, demonstrating how 3D spectroscopy is able to improve the limited accuracy of background subtraction which one would normally obtain with classical slit spectroscopy. It is shown that due to the absence of slit effects, 3D is a most suitable technique for spectrophometry. We present spectra and line intensities for 5 XPN in M31, obtained with the MPFS instrument at the Russian 6m BTA, INTEGRAL at the WHT, and with PMAS at the Calar Alto 3.5m Telescope. Using 3D spectra of bright standard stars, we demonstrate that the PSF is sampled with high accuracy, providing a centroiding precision at the milli-arcsec level. Crowded field 3D spectrophotometry and the use of PSF fitting techniques is suggested as the method of choice for a number of similar observational problems, including luminous stars in nearby galaxies, supernovae, QSO host galaxies, gravitationally lensed QSOs, and others.Comment: (1) Astrophysikalisches Institut Potsdam, (2) University of Durham. 18 pages, 11 figures, accepted for publication in Ap

Simulating the optical performance of a small-sized telescope with secondary optics for the Cherenkov Telescope Array

The Gamma-ray Cherenkov Telescope (GCT) is a small-sized telescope (SST) that represents one of three novel designs that are based on Schwarzschild–Couder optics and are proposed for use within the Cherenkov Telescope Array (CTA). The GAmma-ray Telescope Elements (GATE) program has led an effort to build a prototype of the GCT at the Paris Observatory in Meudon, France. The mechanical structure of the prototype, known as the SST-GATE prototype telescope, is now complete along with the successful installation of the camera. We present the results of extensive simulation work to determine the optical performance of the SST-GATE prototype telescope. Using the ROBAST software and assuming an ideal optical system, we find the radius of the encircled point spread function (θ80) of the SST-GATE to be ∼1.3 arcmin (∼0.02°) for an on-axis (θfield=0∘) observation and ∼3.6 arcmin (∼0.06°) for an observation at the edge of the field of view (θfield=4.4∘). In addition, this research highlights the shadowing that results from the stopping of light rays by various telescope components such as the support masts and trusses. It is shown that for on-axis observations the effective collection area decreases by approximately 1 m2 as a result of shadowing components other than the secondary mirror. This is a similar loss (∼11%) to that seen with the current generation of conventional Davies–Cotton (DC) Cherenkov telescopes. An extensive random tolerance analysis was also performed and it was found that certain parameters, especially the secondary mirror z-position and the tip and tilt rotations of the mirrors, are critical in order to contain θ80 within the pixel limit radius for all field angles. In addition, we have studied the impact upon the optical performance of introducing a hole in the center of the secondary mirror for use with pointing and alignment instruments. We find that a small circular area (radius < 150 mm) at the center of the secondary mirror can be used for instrumentation without any significant impact upon optical performance. Finally, we studied the impact of reducing the size of the primary mirror for the prototype telescope and found that this comes at the cost of poorer image quality and light collection efficiency for all field angles, but at a significant cost saving for a one-off prototype

Why do animal eyes have pupils of different shapes?

There is a striking correlation between terrestrial species’ pupil shape and ecological niche (that is, foraging mode and time of day they are active). Species with vertically elongated pupils are very likely to be ambush predators and active day and night. Species with horizontally elongated pupils are very likely to be prey and to have laterally placed eyes. Vertically elongated pupils create astigmatic depth of field such that images of vertical contours nearer or farther than the distance to which the eye is focused are sharp, whereas images of horizontal contours at different distances are blurred. This is advantageous for ambush predators to use stereopsis to estimate distances of vertical contours and defocus blur to estimate distances of horizontal contours. Horizontally elongated pupils create sharp images of horizontal contours ahead and behind, creating a horizontally panoramic view that facilitates detection of predators from various directions and forward locomotion across uneven terrain

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

219 HIV-negative adults ≤70 years with primary CNS lymphoma (PCNSL) were enrolled in the randomized IELSG32 trial. Enrolled patients were randomly assigned to receive methotrexate-cytarabine (arm A), or methotrexate-cytarabine-rituximab (B), or methotrexate-cytarabine-thiotepa-rituximab (MATRix; arm C). A second randomization allocated patients with responsive/stable disease to whole-brain irradiation (WBRT) or carmustine-thiotepa-conditioned autologous transplantation (ASCT). First results, after a median follow-up of 30 months, showed that MATRix significantly improves outcome, with both WBRT and ASCT being similarly effective. However, sound assessment of overall survival (OS), efficacy of salvage therapy, late complications, secondary tumors, and cognitive impairment requires longer follow-up. Herein, we report the results of this trial at a median follow-up of 88 months. As main findings, MATRix was associated with excellent long-lasting outcome, with a 7-year OS of 21%, 37%, and 56% respectively for arms A, B, and C. Notably, patients treated with MATRix and consolidation had a 7-year OS of 70%. The superiority of arm B on arm A suggests a benefit from the addition of rituximab. Comparable efficacy of WBRT and ASCT was confirmed. Salvage therapy was ineffective; benefit was recorded only in patients with late relapse re-treated with methotrexate. Eight (4%) patients developed a second cancer. Importantly, MATRix and ASCT did not result in higher non-relapse mortality or second tumors incidence. Patients who received WBRT experienced impairment in attentiveness and executive functions, whereas patients undergoing ASCT experienced improvement in these functions as well as in memory and quality of life